| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910783066303321 |
|
|
Titolo |
International justice and the Third World : studies in the philosophy of development / / edited by Robin Attfield and Barry Wilkins |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
London ; ; New York : , : Routledge, , 1992 |
|
|
|
|
|
|
|
ISBN |
|
1-134-91486-5 |
1-134-91487-3 |
1-138-41692-4 |
1-280-04878-6 |
9786610048786 |
0-203-42177-9 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (208 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
AttfieldRobin |
WilkinsBarry <1947-> |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
|
|
Soggetti |
|
Economic assistance |
Economic development |
International economic relations |
Social justice |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references (pages [184]-193) and index. |
|
|
|
|
|
|
Nota di contenuto |
|
International Justice and the Third World Studies in the Philosophy ofDevelopment; Copyright; Contents; Acknowledgements; List of Contributors; Introduction; Chapter 1Global justice, capitalism and the Third World; Chapter 2World poverty, justice and equality; Chapter 3Justice, gender and international boundaries; Chapter 4Marxism and universalism: group interests or a shared world?; Chapter 5Sustainability and the right to development; Chapter 6Is there a conflict between environmental protection and the development of the Third World?; Chapter 7Development and environmentalism |
Chapter 8Debt and underdevelopment: the case for cancelling Third World debtsBibliography; Index |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
International Justice and the Third World vindicates belief in global or |
|
|
|
|
|
|
|
|
|
|
|
|
|
universal justice, and explores both liberal and Marxist grounds for such belief. It also investigates the presuppositions of belief in development, and relates it to sustainability, to environmentalism, and to the obligation to cancel Third World debt. |
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910970370203321 |
|
|
Titolo |
Addressing the barriers to pediatric drug development : workshop summary / / Cori Vanchieri, Adrienne Stith Butler, and Andrea Knutsen, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Washington, D.C., : National Academies Press, c2008 |
|
|
|
|
|
|
|
ISBN |
|
0-309-17865-7 |
1-281-80023-6 |
9786611800239 |
0-309-10743-1 |
|
|
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (65 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
ButlerAdrienne Stith |
KnutsenAndrea |
VanchieriCori |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Drugs - Testing - Law and legislation - United States |
Pediatric pharmacology - Law and legislation - United States |
Pediatric pharmacology - Research - United States |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references (p. 41-42). |
|
|
|
|
|
|
Nota di contenuto |
|
""Reviewers""; ""Contents""; ""Summary""; ""1 Introduction""; ""2 Regulatory Framework""; ""3 Current Challenges in Developing and Prescribing Drugs for Children""; ""4 Models for Enhancing Pediatric Drug Development""; ""5 Challenges and Opportunities for the Future""; ""References""; ""Appendixes""; ""Appendix A: Workshop Agenda""; ""Appendix B: Speaker Biographies"" |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Decades of research have demonstrated that children do not respond |
|
|
|
|
|
|
|
|
|
|
to medications in the same way as adults. Differences between children and adults in the overall response to medications are due to profound anatomical, physiological, and developmental differences. Although few would argue that children should receive medications that have not been adequately tested for safety and efficacy, the majority of drugs prescribed for children--50 to 75 percent-- have not been tested in pediatric populations. Without adequate data from such testing, prescribing drugs appropriately becomes challenging for clinicians treating children, from infancy through adolescence. Addressing the Barriers to Pediatric Drug Development is the summary of a workshop, held in Washington, D.C. on June 13, 2006, that was organized to identify barriers to the development and testing of drugs for pediatric populations, as well as ways in which the system can be improved to facilitate better treatments for children. |
|
|
|
|
|
| |